Searchable abstracts of presentations at key conferences in endocrinology

ea0011p506 | Endocrine tumours and neoplasia | ECE2006

A novel germ-line mutation gly321arg in the exon 5 of the ret proto-oncogene detected in a family with familial medullary thyroid carcinoma

Vaclavikova E , Dvorakova S , Duskova J , Vlcek P , Ryska A , Bendlova B

Familial medullary thyroid carcinoma (FMTC) is an autosomal dominant inherited disease, characterized by germ-line mutations in the RET proto-oncogene, mainly in exons 10 and 11, but also in exons 13, 14 and 15. Recently, there were described also mutations in exon 8 and 16 associated with FMTC. In our laboratory the screening of six risk exons of the RET proto-oncogene in 141 families with MTC was performed. 10 families were classified as clinically FMTC. In 4 of them mutatio...

ea0029p1819 | Thyroid cancer | ICEECE2012

Detection of novel genetic changes in the ras genes in papillary thyroid carcinoma

Sykorova V. , Vaclavikova E. , Dvorakova S. , Halkova T. , Ryska A. , Laco J. , Kodetova D. , Kodet R. , Duskova J. , Astl J. , Betka J. , Hoch J. , Cap J. , Vlcek P. , Lukas J. , Bendlova B.

Introduction: Activating point mutations in the RAS genes (H-RAS, K-RAS, N-RAS) are reported in thyroid tumors. The aim of this study was to determine the frequency of RAS mutations in 98 patients with thyroid tumors.Methods: DNA was extracted from 72 fresh frozen thyroid samples and 26 paraffin-embedded formalin-fixed samples. The cohort contained 83 PTCs (56 FVPTCs, 14 mixed follicular-classical types, 11 classical variants and two other rare variants)...